ロード中...
Tinkering under the Hood: Metabolic Optimisation of CAR-T Cell Therapy
Chimeric antigen receptor (CAR)-T cells are one of the most exciting areas of immunotherapy to date. Clinically available CAR-T cells are used to treat advanced haematological B-cell malignancies with complete remission achieved at around 30–40%. Unfortunately, CAR-T cell success rates are even less...
保存先:
| 出版年: | Antibodies (Basel) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8167549/ https://ncbi.nlm.nih.gov/pubmed/33925949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib10020017 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|